IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
Top Cited Papers
- 30 June 2009
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 123 (6), 1244-1252.e2
- https://doi.org/10.1016/j.jaci.2009.03.041
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Negative regulation of IL-17 production by OX40/OX40L interactionCellular Immunology, 2008
- Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathwaysBritish Journal of Dermatology, 2008
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6Clinical Immunology, 2008
- Deficiency of PPARβ/δ in the Epidermis Results in Defective Cutaneous Permeability Barrier Homeostasis and Increased InflammationJournal of Investigative Dermatology, 2008
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJCI Insight, 2008
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationJCI Insight, 2007
- A role for T cell-derived interleukin 22 in psoriatic skin inflammationClinical and Experimental Immunology, 2007
- Cytokine modulation of atopic dermatitis filaggrin skin expressionJournal of Allergy and Clinical Immunology, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006
- High Expression Levels of Keratinocyte Antimicrobial Proteins in Psoriasis Compared with Atopic DermatitisJournal of Investigative Dermatology, 2005